The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Pharmaceutical nanotechnology: from the bench to the market
Open accessAbstract
Background: Nanotechnology is considered a new and rapidly emerging area in the pharmaceutical and medicinal field. Nanoparticles, as drug delivery systems, impart several advantages concerning improved efficacy as well as reduced adverse drug reactions. Main body: Different types of nanosystems have been fabricated including carbon nanotubes, paramagnetic nanoparticles, dendrimers, nanoemulsions, etc. Physicochemical properties of the starting materials and the selected method of preparation play a significant aspect in determining the shape and characteristics of the developed nanoparticles. Dispersion of preformed polymers, coacervation, polymerization, nano-spray drying and supercritical fluid technology are among the most extensively used techniques for the preparation of nanocarriers. Particle size, surface charge, surface hydrophobicity and drug release are the main factors affecting nanoparticles physical stability and biological performance of the incorporated drug. In clinical practice, many nanodrugs have been used for both diagnostic and therapeutic applications and are being investigated for various indications in clinical trials. Nanoparticles are used for the cure of kidney diseases, tuberculosis, skin conditions, Alzheimer’s disease, different types of cancer as well as preparation of COVID-19 vaccines. Conclusion: In this review, we will confer the advantages, types, methods of preparation, characterization methods and some of the applications of nano-systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Among these, nanotechnology‐based approaches have transformed the field by enabling the engineering of nanoscale carriers capable of entrapping, encapsulating, dissolving, or binding active pharmaceutical ingredients (APIs) within their matrix [26].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helical microtubules of graphitic carbon
Iijima, S. (1991) · Nature · doi:10.1038/354056a0 · Cited by 43,126
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,417
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,845
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Preparation and antibacterial activity of chitosan nanoparticles
Qi, L., Xu, Z., Jiang, X., Hu, C., & Zou, X. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.09.007 · Cited by 1,808
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C. H., Lowery, A. R., Halas, N. J., West, J. L., & Drezek, R. A. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
Research works printed but not linked: 6
- Mohanraj V, Chen Y (2006) Nanoparticles-a review. Trop J Pharm Res 5(1):561–573
- Saad ZH, Jahan R, Bagul U (2012) Nanopharmaceuticals: a new perspective of drug delivery system. Asian J Biomed Pharm Sci 2(14):11–20
- Kalele SW, Gosavi S, Urbn J, Kulkarni S (2006) Nanoshell particles: synthesis, properties and applications. Curr Sci 91(8):1038–1052
- Kompella U, Bandi N, Ayalasomayajula S (2001) Poly (lactic acid) nanoparticles for sustained release of budesonide. Drug Deliv Technol 1:1–7
- Shinde NC, Keskar NJ, Argade PD (2012) Nanoparticles: advances in drug delivery systems. Res J Pharm Biol Chem Sci 3:922–929
- Jahangiri A, Barghi L (2018) Polymeric nanoparticles: review of synthesismethods and applications in drug delivery. J Adv Chem Pharm Mater 1(2):38–47
Cited by
Sorted by citations
Items 201–208 of 208
Saeed, H. Y., Orabi, S. H., Mansour, D. A., Korany, R. M. S., Alsofany, J. M., & Mousa, A. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154137 · Cited by 1
Future Outlook of Nanopharmacy: Challenges and Opportunities
Chandola, A., Pandey, R., Nautiyal, U., & Anwar, F. (2026) · Reference series in phytochemistry · doi:10.1007/978-3-031-69044-0_26-1
Azad, A. K., & Chi, T. S. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.102646
Dixit, S., Deora, S., Nathawat, P., & Ganguly, M. (2026) · Nanoscale Advances · doi:10.1039/d6na00268d
Pawar, A., Naktode, K., Mungole, A. J., Gaikwad, S., Parshuramkar, D. M., Pandhurnekar, C. P., Gulzar, J., Mammen, M. V., & Rasool, A. (2026) · Die Naturwissenschaften · doi:10.1007/s00114-026-02161-9
Nanoparticle Behavior in the Body: Biochemical, Pharmacological and Cellular Aspects
Sakhabeev, R. G., Ilina, A. V., Gorbacheva, I. A., Sezganova, E. N., Rogova, A. S., Sagaidak, A. V., Олегович, В. Д., & Shevtsov, M. A. (2026) · Nanomaterials · doi:10.3390/nano16191195
Vignesh, N., Kayal, P., ALLIMALARKODI, S., & Mishra, M. K. (2026) · Human Gene · doi:10.1016/j.humgen.2026.201603
Keche, P., Ganesh, P., & Jain, S. N. (2026) · Journal of Microencapsulation · doi:10.1080/02652048.2026.2734903
Metadata
- Authors
- Mazayen, Z. M., Ghoneim, A. M., Elbatanony, R. S., Basalious, E. B., & Bendas, E. R.
- Affiliations
- Future University in Egypt (EG)
- Cairo University (EG)
- Corresponding author
- Ghoneim, Amira M.
- Venue
- Future Journal of Pharmaceutical Sciences
- Published
- 2022-01-15
- Volume
- 8
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2314-7245 (ISSN-L)
- 2314-7253
- PMC
- PMC8760885
- OpenAlex
- W4205766471
- Cited by
- 208
- References
- 109
- Citations by year
- 2026: 33 · 2025: 58 · 2024: 57 · 2023: 51 · 2022: 9
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Future Journal of Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Keywords
- pharmaceutical nanotechnology, nanoparticles, drug delivery systems, nanocarriers, carbon nanotubes, paramagnetic nanoparticles, dendrimers, nanoemulsions, coacervation, nano spray drying, supercritical fluid technology, particle size, surface charge, drug release, physical stability, clinical trials, nanotherapeutics, COVID-19 vaccines, cancer therapy, Alzheimer's disease, tuberculosis, kidney disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
